Sign in →

Test Code CRUZI Trypanosoma cruzi (Chagas) Antibody Panel, Serum


Specimen Required


Supplies: Sarstedt Aliquot Tube 5 mL (T914)

Collection Container/Tube:

Preferred: Serum gel

Acceptable: Red top

Submission Container/Tube: Plastic vial

Specimen Volume: 0.7 mL

Collection Instructions: Centrifuge and aliquot serum into a plastic vial.


Useful For

Diagnosis of chronic Trypanosoma cruzi infection (Chagas disease) using two different methods

Profile Information

Test ID Reporting Name Available Separately Always Performed
CHAGS T. cruzi Total Ab, EIA, S No Yes
CHAGL T. cruzi IgG, LFA, S No Yes
CHAGI T. cruzi Interpretation No Yes

Method Name

CHAGS: Enzyme-Linked Immunosorbent Assay (ELISA)

CHAGL: Lateral Flow Assay (LFA)

Reporting Name

T. cruzi (Chagas) Ab Panel, S

Specimen Type

Serum

Specimen Minimum Volume

0.5 mL

Specimen Stability Information

Specimen Type Temperature Time
Serum Frozen 14 days

Reference Values

Negative

 

Reference values apply to all ages.

Interpretation

CHAGS result

CHAGL result

Interpretive comment

Positive

Positive

Antibodies to Trypanosoma cruzi (Chagas disease) detected by two separate methods, suggesting current or past infection. Results should be interpreted alongside clinical presentation and exposure history.

Positive

Negative

Antibodies to Trypanosoma cruzi (Chagas disease) detected by one of two assays. Discordant results can be resolved through submission of a new sample for testing or through additional testing at a public health laboratory.

Positive

Invalid

Submission of a new sample is recommended to resolve discordant results.

Indeterminate

Positive

Antibodies to Trypanosoma cruzi (Chagas disease) detected by one of two assays. Discordant results can be resolved through submission of a new sample for testing or through additional testing at a public health laboratory.

Indeterminate

Negative

Submission of a new sample is recommended to resolve discordant results.

Indeterminate

Invalid

Submission of a new sample is recommended to resolve discordant results.

Negative

Positive

Antibodies to Trypanosoma cruzi (Chagas disease) detected by one of two assays. Discordant results can be resolved through submission of a new sample for testing or through additional testing at a public health laboratory.

Negative

Negative

No antibodies to Trypanosoma cruzi (Chagas disease) detected. False negative results may occur in patients tested within 4 weeks of infection.

Negative

Invalid

Submission of a new sample is recommended to resolve discordant results.

Clinical Reference

1. Bern C, Montgomery SP, Herwaldt BL, et al. Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA. 2007;298(18):2171-2181

2. Bern C, Messenger LA, Whitman JD, Maguire JH. Chagas disease in the United States: a public health approach. Clin Microbiol Rev. 2019;33(1):e00023-19. doi:10.1128/CMR.00023-19

3. Forsyth CJ, Manne-Goehler J, Bern C, et al. Recommendations for screening and diagnosis of Chagas disease in the United States. J Infect Dis. 2022;225(9):1601-1610. doi:10.1093/infdis/jiab513

Day(s) Performed

Monday

Report Available

Same day/1 to 8 days

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.

CPT Code Information

86753 x2

LOINC Code Information

Test ID Test Order Name Order LOINC Value
CRUZI T. cruzi (Chagas) Ab Panel, S 23785-9

 

Result ID Test Result Name Result LOINC Value
CHAGS T. cruzi Total Ab, EIA, S 57320-4
CHAGL T. cruzi IgG, LFA, S 87994-0
CHAGI T. cruzi Interpretation 59464-8

Forms

If not ordering electronically, complete, print, and send Infectious Disease Serology Test Request (T916) with the specimen.